These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 25193665)

  • 1. Structural basis for the binding specificity of human Recepteur d'Origine Nantais (RON) receptor tyrosine kinase to macrophage-stimulating protein.
    Chao KL; Gorlatova NV; Eisenstein E; Herzberg O
    J Biol Chem; 2014 Oct; 289(43):29948-60. PubMed ID: 25193665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of the Sema-PSI extracellular domain of human RON receptor tyrosine kinase.
    Chao KL; Tsai IW; Chen C; Herzberg O
    PLoS One; 2012; 7(7):e41912. PubMed ID: 22848655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The soluble sema domain of the RON receptor inhibits macrophage-stimulating protein-induced receptor activation.
    Angeloni D; Danilkovitch-Miagkova A; Miagkov A; Leonard EJ; Lerman MI
    J Biol Chem; 2004 Jan; 279(5):3726-32. PubMed ID: 14597639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage stimulating protein preserves blood brain barrier integrity after intracerebral hemorrhage through recepteur d'origine nantais dependent GAB1/Src/β-catenin pathway activation in a mouse model.
    Lu T; Wang Z; Prativa S; Xu Y; Wang T; Zhang Y; Yu L; Xu N; Tang J; You W; Chen G; Zhang JH
    J Neurochem; 2019 Jan; 148(1):114-126. PubMed ID: 30380151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recepteur d'origine nantais tyrosine kinase is a direct target of hypoxia-inducible factor-1alpha-mediated invasion of breast carcinoma cells.
    Thangasamy A; Rogge J; Ammanamanchi S
    J Biol Chem; 2009 May; 284(21):14001-10. PubMed ID: 19307182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional consequences of the macrophage stimulating protein 689C inflammatory bowel disease risk allele.
    Kauder SE; Santell L; Mai E; Wright LY; Luis E; N'Diaye EN; Lutman J; Ratti N; Sa SM; Maun HR; Stefanich E; Gonzalez LC; Graham RR; Diehl L; Faubion WA; Keir ME; Young J; Chaudhuri A; Lazarus RA; Egen JG
    PLoS One; 2013; 8(12):e83958. PubMed ID: 24409221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage-stimulating protein and RON receptor tyrosine kinase: potential regulators of macrophage inflammatory activities.
    Wang MH; Zhou YQ; Chen YQ
    Scand J Immunol; 2002 Dec; 56(6):545-53. PubMed ID: 12472665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage-stimulating protein, the ligand for the stem cell-derived tyrosine kinase/RON receptor tyrosine kinase, inhibits IL-12 production by primary peritoneal macrophages stimulated with IFN-gamma and lipopolysaccharide.
    Morrison AC; Wilson CB; Ray M; Correll PH
    J Immunol; 2004 Feb; 172(3):1825-32. PubMed ID: 14734766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic and invasive potentials of human macrophage-stimulating protein receptor, the RON receptor tyrosine kinase.
    Wang MH; Wang D; Chen YQ
    Carcinogenesis; 2003 Aug; 24(8):1291-300. PubMed ID: 12807733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein characterization of a candidate mechanism SNP for Crohn's disease: the macrophage stimulating protein R689C substitution.
    Gorlatova N; Chao K; Pal LR; Araj RH; Galkin A; Turko I; Moult J; Herzberg O
    PLoS One; 2011; 6(11):e27269. PubMed ID: 22087277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The MSP-RON axis stimulates cancer cell growth in models of triple negative breast cancer.
    Millar R; Kilbey A; Remak SJ; Severson TM; Dhayade S; Sandilands E; Foster K; Bryant DM; Blyth K; Coffelt SB
    Mol Oncol; 2020 Aug; 14(8):1868-1880. PubMed ID: 32484599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of MSP-RON signaling pathway in cancer cells by a novel soluble form of RON comprising the entire sema sequence.
    Ma Q; Zhang K; Yao HP; Zhou YQ; Padhye S; Wang MH
    Int J Oncol; 2010 Jun; 36(6):1551-61. PubMed ID: 20428780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MSP-RON Pathway: Potential Regulator of Inflammation and Innate Immunity.
    Huang L; Fang X; Shi D; Yao S; Wu W; Fang Q; Yao H
    Front Immunol; 2020; 11():569082. PubMed ID: 33117355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a novel recepteur d'origine nantais/c-met small-molecule kinase inhibitor with antitumor activity in vivo.
    Zhang Y; Kaplan-Lefko PJ; Rex K; Yang Y; Moriguchi J; Osgood T; Mattson B; Coxon A; Reese M; Kim TS; Lin J; Chen A; Burgess TL; Dussault I
    Cancer Res; 2008 Aug; 68(16):6680-7. PubMed ID: 18701492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of the beta-chain of human hepatocyte growth factor-like/macrophage stimulating protein.
    Carafoli F; Chirgadze DY; Blundell TL; Gherardi E
    FEBS J; 2005 Nov; 272(22):5799-807. PubMed ID: 16279944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterizing the Hot Spots Involved in RON-MSPβ Complex Formation Using
    Zarei O; Hamzeh-Mivehroud M; Benvenuti S; Ustun-Alkan F; Dastmalchi S
    Adv Pharm Bull; 2017 Apr; 7(1):141-150. PubMed ID: 28507948
    [No Abstract]   [Full Text] [Related]  

  • 17. Macrophage stimulating protein (MSP) binds to its receptor via the MSP beta chain.
    Wang MH; Julian FM; Breathnach R; Godowski PJ; Takehara T; Yoshikawa W; Hagiya M; Leonard EJ
    J Biol Chem; 1997 Jul; 272(27):16999-7004. PubMed ID: 9202013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenesis of RON receptor tyrosine kinase: a molecular target for malignant epithelial cancers.
    Wang MH; Yao HP; Zhou YQ
    Acta Pharmacol Sin; 2006 Jun; 27(6):641-50. PubMed ID: 16723080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of functional domains in the hepatocyte growth factor and its receptor by molecular engineering.
    Bardelli A; Ponzetto C; Comoglio PM
    J Biotechnol; 1994 Sep; 37(2):109-22. PubMed ID: 7765452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenic signaling pathways activated by RON receptor tyrosine kinase.
    Danilkovitch-Miagkova A
    Curr Cancer Drug Targets; 2003 Feb; 3(1):31-40. PubMed ID: 12570659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.